诺华Rhapsido在二期食物过敏试验数据中展现潜力。
Novartis' Rhapsido shows promise in Phase 2 food allergy data
生物技术与制药领域的最新动态
Novartis' Rhapsido shows promise in Phase 2 food allergy data
Lonza Group AG Stock: Quiet Swiss Biotech Giant You Should Not Ignore - AD HOC NEWS
Citrate clearance is a major function of aconitase 2 in the canonical TCA cycle
Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation
High-resolution in situ structures of hantavirus glycoprotein tetramers
Merck looks to expand Welireg label following combo readouts with Keytruda, Lenvima
Agilent Technologies, Inc. $A Shares Acquired by Findlay Park Partners LLP - MarketBeat
Harvest Portfolios Group Inc. Sells 4,403 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Findlay Park Partners LLP Reduces Holdings in Waters Corporation $WAT - MarketBeat
Agilent’s New FDA Approval And What It Could Mean For Investors - simplywall.st
Mitsubishi UFJ Asset Management Co. Ltd. Has $73.79 Million Stock Position in Agilent Technologies, Inc. $A - MarketBeat
GLP-1 news galore; Top 100 venture investors; Doug Ingram to step down; and more
How Does Thermo Fisher Scientific Stock Stack Up Against Its Peers? - Trefis
Artisan Partners Limited Partnership Sells 34,925 Shares of Waters Corporation $WAT - MarketBeat
Illumina, Inc. $ILMN Position Boosted by Citigroup Inc. - MarketBeat
Agilent Technologies Stock: Analyst Estimates & Ratings - National Today
Thermo Fisher Scientific (NYSE:TMO) Upgraded at Wall Street Zen - MarketBeat
How Does Thermo Fisher Scientific Stock Stack Up Against Its Peers? - Trefis
BioNTech advances DualityBio ADC into phase 3 with half the patients of Merck-Daiichi rival
Ascendis wins FDA approval for achondroplasia drug, waits on EU action